Date | Capital Expenditure | Free Cash Flow | Depreciation And Amortization | Deferred Income Tax |
---|
CEO | Mr. Morten Henneveld |
IPO Date | May 24, 2019 |
Location | Sweden |
Headquarters | Rapsgatan 23 A |
Employees | 41 |
Sector | Technology |
Industries |
OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in Sweden, Germany, the United States, the United Kingdom, rest of Europe, and internationally. The company's products include OSSDSIGN cranial, an implant solution and related accessories for skull defect reconstruction in cranioplasty patients; and OSSDSIGN facial to treat post-traumatic skeletal deformities and congenital skeletal defects. It also offers OSSDSIGN Cranioplug for bone flap fixation and burr hole coverage; and OssDsign Catalyst, a nanosynthetic bone graft substitute that stimulates the formation of healthy bone tissue. The company was incorporated in 2011 and is headquartered in Uppsala, Sweden.
Past 5 years
USD 30.85
StockViz Staff
February 5, 2025
Any question? Send us an email